首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Pharmacoeconomics-open

缩写:

ISSN:2509-4262

e-ISSN:2509-4254

IF/分区:2.1/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引634
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Fatma Maraiki,J Byrnes,H Tuffaha et al. Fatma Maraiki et al.
Objectives: The aim of this study was to compare the listing success rates and time incurred to listing of recently approved lung cancer medications across Australia, Canada and England. ...
Thomas Butt Thomas Butt
Decision aids, sometimes known as decision-support tools, are increasingly used to help patients to understand treatment options and to reach an informed decision consistent with their own values, yet methods for their economic evaluation h...
Jing Shen,Sarah Hill,David Mott et al. Jing Shen et al.
Time trade-off (TTO) is an established method in health economics to elicit and value individuals' preferences for different health states. These preferences are expressed in the form of health-state utilities that are typically used to mea...
Alex Diamantopoulos,Toby M Maher,Nils Schoof et al. Alex Diamantopoulos et al.
Background: Disease progression and acute exacerbations in patients with idiopathic pulmonary fibrosis (IPF) are associated with high morbidity and mortality. They usually require a visit to a specialist or a general prac...
Koji Makino,Dominic Tilden,Carmel Guarnieri et al. Koji Makino et al.
Background: In Australia, the reimbursement of botulinum neurotoxin-A (BoNT-A) on the Pharmaceutical Benefits Scheme for the treatment of moderate to severe spasticity of the upper limb following a stroke (PSS-UL) is rest...
David G T Whitehurst,Nicholas R Latimer,Aura Kagan et al. David G T Whitehurst et al.
A key component of the current framework for economic evaluation is the measurement and valuation of health outcomes using generic preference-based health-related quality-of-life (HRQoL) instruments. In 2015, a research synthesis reported t...
Meryl Brod,Jane F Beck,Lise Højbjerre et al. Meryl Brod et al.
Background: This study's purpose was to assess the minimal important difference (MID) for the Treatment-Related Impact Measure-Adult Growth Hormone Deficiency (TRIM-AGHD), a patient-reported outcome measure assessing grow...
Pedro Plans-Rubió,Encarna Navas,Pere Godoy et al. Pedro Plans-Rubió et al.
Objectives: The aim of this study was to assess direct health costs in children with pertussis aged 0-9 years who were vaccinated, partially vaccinated, and unvaccinated during childhood, and to assess the association bet...
Denise Razzouk Denise Razzouk
Background: Health costs are the main hindrances for expanding community mental health services. Exploring patient profiles and cost predictors may be useful for optimising financial resources. However, the deinstitutiona...